• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将新冠病毒变异株的突变情况和依病例而定的疫苗接种率纳入流行病模型。

Incorporating the mutational landscape of SARS-COV-2 variants and case-dependent vaccination rates into epidemic models.

作者信息

Chowdhury Mohammad Mihrab, Islam Md Rafiul, Hossain Md Sakhawat, Tabassum Nusrat, Peace Angela

机构信息

Department of Mathematics and Statistics, Texas Tech University, Lubbock, TX, USA.

Department of Mathematics, Iowa State University, Ames, IA, USA.

出版信息

Infect Dis Model. 2022 Jun;7(2):75-82. doi: 10.1016/j.idm.2022.02.003. Epub 2022 Mar 11.

DOI:10.1016/j.idm.2022.02.003
PMID:35291223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8913432/
Abstract

Coronavirus Disease (COVID-19), which began as a small outbreak in Wuhan, China, in December 2019, became a global pandemic within months due to its high transmissibility. In the absence of pharmaceutical treatment, various non-pharmaceutical interventions (NPIs) to contain the spread of COVID-19 brought the entire world to a halt. After almost a year of seemingly returning to normalcy with the world's quickest vaccine development, the emergence of more infectious and vaccine resistant coronavirus variants is bringing the situation back to where it was a year ago. In the light of this new situation, we conducted a study to portray the possible scenarios based on the three key factors: impact of interventions (pharmaceutical and NPIs), vaccination rate, and vaccine efficacy. In our study, we assessed two of the most crucial factors, transmissibility and vaccination rate, in order to reduce the spreading of COVID-19 in a simple but effective manner. In order to incorporate the time-varying mutational landscape of COVID-19 variants, we estimated a weighted transmissibility composed of the proportion of existing strains that naturally vary over time. Additionally, we consider time varying vaccination rates based on the number of daily new cases. Our method for calculating the vaccination rate from past active cases is an effective approach in forecasting probable future scenarios as it actively tracks people's attitudes toward immunization as active case changes. Our simulations show that if a large number of individuals cannot be vaccinated by ensuring high efficacy in a short period of time, adopting NPIs is the best approach to manage disease transmission with the emergence of new vaccine breakthrough and more infectious variants.

摘要

冠状病毒病(COVID-19)于2019年12月在中国武汉开始小规模爆发,由于其高传播性,在数月内便成为全球大流行病。在缺乏药物治疗的情况下,为遏制COVID-19传播而采取的各种非药物干预措施(NPIs)使整个世界陷入停滞。在经过近一年看似恢复正常的状态后,随着世界上最快的疫苗研发成功,更具传染性且对疫苗耐药的冠状病毒变种的出现又使情况回到了一年前。鉴于这种新情况,我们开展了一项研究,以基于三个关键因素描绘可能出现的情景:干预措施(药物和非药物干预)的影响、疫苗接种率和疫苗效力。在我们的研究中,我们评估了两个最关键的因素,即传播性和疫苗接种率,以便以简单而有效的方式减少COVID-19的传播。为了纳入COVID-19变种随时间变化的突变情况,我们估计了一种加权传播性,它由随时间自然变化的现有毒株比例组成。此外,我们根据每日新增病例数考虑随时间变化的疫苗接种率。我们从过去的活跃病例计算疫苗接种率的方法是预测未来可能情景的一种有效方法,因为它会随着活跃病例的变化积极跟踪人们对免疫接种的态度。我们的模拟表明,如果在短时间内无法通过确保高效力来使大量个体接种疫苗,那么在出现新的疫苗突破和更具传染性的变种时,采用非药物干预措施是控制疾病传播的最佳方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/399ad326f747/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/ad035f304ae6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/9acc4ee3377f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/c29fd920deb5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/54b9b5950a92/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/399ad326f747/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/ad035f304ae6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/9acc4ee3377f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/c29fd920deb5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/54b9b5950a92/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8122/8983375/399ad326f747/gr5.jpg

相似文献

1
Incorporating the mutational landscape of SARS-COV-2 variants and case-dependent vaccination rates into epidemic models.将新冠病毒变异株的突变情况和依病例而定的疫苗接种率纳入流行病模型。
Infect Dis Model. 2022 Jun;7(2):75-82. doi: 10.1016/j.idm.2022.02.003. Epub 2022 Mar 11.
2
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
3
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.非药物干预措施、疫苗接种和 SARS-CoV-2 德尔塔变异株在英国:一项数学建模研究。
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.
4
Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.加拿大努纳武特地区非药物干预和疫苗接种对 COVID-19 疫情的影响:加拿大免疫研究网络(CIRN)研究。
BMC Public Health. 2022 May 25;22(1):1042. doi: 10.1186/s12889-022-13432-1.
5
Non Pharmaceutical Interventions for Optimal Control of COVID-19.非药物干预措施以实现 COVID-19 的最佳控制。
Comput Methods Programs Biomed. 2020 Nov;196:105642. doi: 10.1016/j.cmpb.2020.105642. Epub 2020 Jul 7.
6
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?解除新冠肺炎大流行后的非药物干预措施——暴风雨前的宁静?
Expert Rev Vaccines. 2022 Nov;21(11):1541-1553. doi: 10.1080/14760584.2022.2117693. Epub 2022 Sep 5.
7
Tuberculosis结核病
8
Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19.疫苗接种作为非药物干预措施的替代方案,以预防 COVID-19 在当地的再次爆发。
Infect Dis Poverty. 2022 Mar 26;11(1):36. doi: 10.1186/s40249-022-00960-6.
9
Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.模拟 COVID-19 疫苗接种和非药物干预措施与感染、住院和死亡的关联。
JAMA Netw Open. 2021 Jun 1;4(6):e2110782. doi: 10.1001/jamanetworkopen.2021.10782.
10
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.意大利疫苗接种推广、新冠病毒变异株及非药物干预措施需求的建模
Nat Med. 2021 Jun;27(6):993-998. doi: 10.1038/s41591-021-01334-5. Epub 2021 Apr 16.

引用本文的文献

1
Incorporating social determinants of health into transmission modeling of COVID-19 vaccine in the US: a scoping review.将健康的社会决定因素纳入美国 COVID-19 疫苗传播模型:一项范围综述。
Lancet Reg Health Am. 2024 Jun 7;35:100806. doi: 10.1016/j.lana.2024.100806. eCollection 2024 Jul.

本文引用的文献

1
Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis.评估无症状新冠病毒感染的程度及其社区传播潜力:系统评价与荟萃分析。
J Assoc Med Microbiol Infect Dis Can. 2020 Dec 31;5(4):223-234. doi: 10.3138/jammi-2020-0030. eCollection 2020 Dec.
2
Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant.接种疫苗和未接种疫苗、无症状和有症状的感染新冠病毒德尔塔变异株者的病毒载量
Open Forum Infect Dis. 2022 Mar 17;9(5):ofac135. doi: 10.1093/ofid/ofac135. eCollection 2022 May.
3
Vaccine efficacy and SARS-CoV-2 control in California and U.S. during the session 2020-2026: A modeling study.
2020 - 2026年期间加利福尼亚州和美国的疫苗效力与新冠病毒控制:一项建模研究
Infect Dis Model. 2022 Mar;7(1):62-81. doi: 10.1016/j.idm.2021.11.002. Epub 2021 Nov 27.
4
Evaluation of the United States COVID-19 vaccine allocation strategy.评估美国 COVID-19 疫苗分配策略。
PLoS One. 2021 Nov 17;16(11):e0259700. doi: 10.1371/journal.pone.0259700. eCollection 2021.
5
Predicting the effective reproduction number of COVID-19: inference using human mobility, temperature, and risk awareness.预测 COVID-19 的有效繁殖数:使用人类流动性、温度和风险意识进行推断。
Int J Infect Dis. 2021 Dec;113:47-54. doi: 10.1016/j.ijid.2021.10.007. Epub 2021 Oct 8.
6
A model and predictions for COVID-19 considering population behavior and vaccination.考虑人口行为和疫苗接种的 COVID-19 模型和预测。
Sci Rep. 2021 Jun 8;11(1):12051. doi: 10.1038/s41598-021-91514-7.
7
Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021.基于疫苗接种率和非药物干预情景的未来 COVID-19 病例、住院和死亡建模-美国,2021 年 4 月至 9 月。
MMWR Morb Mortal Wkly Rep. 2021 May 14;70(19):719-724. doi: 10.15585/mmwr.mm7019e3.
8
Tracking [Formula: see text] of COVID-19: A new real-time estimation using the Kalman filter.追踪 COVID-19 [公式:见正文]:一种新的基于卡尔曼滤波的实时估计方法。
PLoS One. 2021 Jan 13;16(1):e0244474. doi: 10.1371/journal.pone.0244474. eCollection 2021.
9
Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity - United States, January 26-October 3, 2020.与 COVID-19 相关的超额死亡人数,按年龄、种族和族裔划分 - 美国,2020 年 1 月 26 日至 10 月 3 日。
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1522-1527. doi: 10.15585/mmwr.mm6942e2.
10
The COVID-19 Pandemic and the $16 Trillion Virus.新冠疫情与“16万亿美元病毒”
JAMA. 2020 Oct 20;324(15):1495-1496. doi: 10.1001/jama.2020.19759.